1. Home
  2. ARMP vs SHIM Comparison

ARMP vs SHIM Comparison

Compare ARMP & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • SHIM
  • Stock Information
  • Founded
  • ARMP N/A
  • SHIM 1990
  • Country
  • ARMP United States
  • SHIM United States
  • Employees
  • ARMP N/A
  • SHIM N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • SHIM
  • Sector
  • ARMP Health Care
  • SHIM
  • Exchange
  • ARMP Nasdaq
  • SHIM Nasdaq
  • Market Cap
  • ARMP 80.0M
  • SHIM 83.1M
  • IPO Year
  • ARMP N/A
  • SHIM 2023
  • Fundamental
  • Price
  • ARMP $2.06
  • SHIM $2.70
  • Analyst Decision
  • ARMP Strong Buy
  • SHIM Hold
  • Analyst Count
  • ARMP 1
  • SHIM 2
  • Target Price
  • ARMP $7.00
  • SHIM $3.00
  • AVG Volume (30 Days)
  • ARMP 13.8K
  • SHIM 82.7K
  • Earning Date
  • ARMP 11-13-2024
  • SHIM 11-12-2024
  • Dividend Yield
  • ARMP N/A
  • SHIM N/A
  • EPS Growth
  • ARMP N/A
  • SHIM N/A
  • EPS
  • ARMP N/A
  • SHIM N/A
  • Revenue
  • ARMP $5,467,000.00
  • SHIM $514,746,000.00
  • Revenue This Year
  • ARMP $23.87
  • SHIM N/A
  • Revenue Next Year
  • ARMP N/A
  • SHIM $3.01
  • P/E Ratio
  • ARMP N/A
  • SHIM N/A
  • Revenue Growth
  • ARMP 34.92
  • SHIM N/A
  • 52 Week Low
  • ARMP $1.80
  • SHIM $1.47
  • 52 Week High
  • ARMP $4.48
  • SHIM $7.99
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 49.88
  • SHIM 52.26
  • Support Level
  • ARMP $1.97
  • SHIM $2.20
  • Resistance Level
  • ARMP $2.28
  • SHIM $3.05
  • Average True Range (ATR)
  • ARMP 0.14
  • SHIM 0.26
  • MACD
  • ARMP 0.01
  • SHIM -0.02
  • Stochastic Oscillator
  • ARMP 54.17
  • SHIM 47.62

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About SHIM Shimmick Corporation

Shimmick Corp is a leading provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

Share on Social Networks: